{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno"
    },
    "document_metadata": {
      "authors": "Sandra Spalek",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2019 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "PUBCHEM": "^\\d+$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/chebi-names.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/501ceccdc9a27d97edbdc48a89ebe8e1dd3626e9/export/conso-names.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/mesh-names.belns"
    },
    "namespaces_uncached": [],
    "path": "anatabine/paris2011.bel",
    "pybel_version": "0.13.2"
  },
  "links": [
    {
      "annotations": {
        "CellLine": {
          "CHO cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "Anatabine dose dependently inhibited Aβ1–40 and Aβ1–42 with an approximate half maximal inhibitory concentration of 640 μg/ml for both Aβ1–40 and Aβ1–42 (Fig. 2).",
      "key": "570b149471446ab832c4921551ca81f07f85c0526f957ae849e306d82ab45f7856dbc94f8d3379ed301ca990643164d85c7a5c3c8e93f91a8a6a1f67942c38d7",
      "line": 81,
      "relation": "decreases",
      "source": 3,
      "target": 1
    },
    {
      "annotations": {
        "CellLine": {
          "CHO cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "We then tested the impact of anatabine on sAPPα and sAPPβ production using 7W CHO cells and observed that anatabine inhibits sAPPβ secretion without impacting sAPPα suggesting that anatabine is preventing the β-cleavage of APP (Fig. 4).",
      "key": "463edcc191e4bad0a4962af426ebd14dad792b5e5c30d19431a5fb507b715d8a8516e321576cf579c8b472f2ef207ac38b5f833f396466a24bf7986c9244ac77",
      "line": 116,
      "relation": "decreases",
      "source": 3,
      "target": 1
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "A significant reduction in the accumulation of brain soluble and insoluble Aβ1–40 and Aβ1–42 was observed following four days of treatment with 2 mg/kg of anatabine (Fig. 9).",
      "key": "b640ac6bef0fcdbed017be8755e00263a0f4e979d0030c431758a4ca475ed6220ea6bd0da5eefce9da8c3e4b61d417637a9ca3ff2657bfd31d7fda4a35280e32",
      "line": 182,
      "relation": "decreases",
      "source": 3,
      "target": 1
    },
    {
      "annotations": {
        "CellLine": {
          "CHO cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "Anatabine dose dependently inhibited Aβ1–40 and Aβ1–42 with an approximate half maximal inhibitory concentration of 640 μg/ml for both Aβ1–40 and Aβ1–42 (Fig. 2).",
      "key": "bc7513609b543455bf8094e12d493c6a73e513f0afdafac076fd0170faacec3a77e089c2d37683b526ffcbc27e879394fec5e3ae40f35d57dfc9214290e953f9",
      "line": 82,
      "relation": "decreases",
      "source": 3,
      "target": 0
    },
    {
      "annotations": {
        "CellLine": {
          "CHO cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "We then tested the impact of anatabine on sAPPα and sAPPβ production using 7W CHO cells and observed that anatabine inhibits sAPPβ secretion without impacting sAPPα suggesting that anatabine is preventing the β-cleavage of APP (Fig. 4).",
      "key": "0c23b2944f3176d5c0477fd82ec6fe20656590f691d09025b4457c9f4fe549eb9e5ec16900cadc4011f5b52cec9217331ddce07ee3277504342b02e9f39f5a59",
      "line": 117,
      "relation": "decreases",
      "source": 3,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "A significant reduction in the accumulation of brain soluble and insoluble Aβ1–40 and Aβ1–42 was observed following four days of treatment with 2 mg/kg of anatabine (Fig. 9).",
      "key": "aa7d518b20522e3673c6691a07f361240cbbe742cddcc7e28643f208abd18c7cc3c5dd859beb38d10f33e02b1eec60eaf85a62dd398a52879992e232aa0f68d2",
      "line": 183,
      "relation": "decreases",
      "source": 3,
      "target": 0
    },
    {
      "annotations": {
        "CellLine": {
          "CHO cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "No cytotoxicity was observed (as measured by the release of lactate dehydrogenase in the culture medium of 7W CHO cells) with the dose range of anatabine tested (data not shown).",
      "key": "57715a3a7534c3b02d71ff7978e61e00cfb2ebaa31fa527cc746fae78cadc44a5cea5837ef53f44b2ce51540151895173e9b11c8ad42f3b14694cc62fc464e3a",
      "line": 89,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "causesNoChange",
      "source": 3,
      "target": 17
    },
    {
      "annotations": {
        "CellLine": {
          "CHO cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "Contrary to anatabine, (−)-nicotine and other nicotinic acetylcholine receptors agonists and antagonists do not inhibit Aβ production by 7W CHO cells (Fig. 3).",
      "key": "7027d0a2798efc1393e84c54d429f8836245ae63c947f21d033efd5ce80cebc04bfa7e6710d9d1430ba73e9bfb565de88583a54b4b0cf02fce9dcf0412967185",
      "line": 97,
      "relation": "decreases",
      "source": 3,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Plasma": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "In addition, a significant decreased in plasma Aβ levels was observed in mice treated with anatabine consistent with an inhibition of Aβ production (Fig. 10).",
      "key": "53a605bf9a8cbfc0348a1348c922ba8f31e6509c00d67be098aa097141ee4b6cb3ee940e9fafafcb795cdb398e952c44a7b13b0edccc26abdb74c62a3a1ec97c",
      "line": 192,
      "relation": "decreases",
      "source": 3,
      "target": 2
    },
    {
      "annotations": {
        "CellLine": {
          "CHO cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "We then tested the impact of anatabine on sAPPα and sAPPβ production using 7W CHO cells and observed that anatabine inhibits sAPPβ secretion without impacting sAPPα suggesting that anatabine is preventing the β-cleavage of APP (Fig. 4).",
      "key": "5716d13b9b4d06aff917eaef8c1db708e6c65531470c4cf945b3f245f1b6bb0886203d01f128a33453613fa229d7e28c7fa56804b999c413dc7bd75c2957b229",
      "line": 114,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 3,
      "target": 14
    },
    {
      "annotations": {
        "CellLine": {
          "CHO cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "We then tested the impact of anatabine on sAPPα and sAPPβ production using 7W CHO cells and observed that anatabine inhibits sAPPβ secretion without impacting sAPPα suggesting that anatabine is preventing the β-cleavage of APP (Fig. 4).",
      "key": "f3f115473f88f1ccbcd24e2716e14b3bdf6f16b7d27909d7e8dbb54489a773e923c4c06de5f391b668139873cd4bc0c423254a578f9a4c3d69da860f589841d7",
      "line": 115,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "causesNoChange",
      "source": 3,
      "target": 13
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "We observed that anatabine dose dependently inhibited NFκB activation by TNFα in HEK293 NFκB luciferase reporter cells (Fig. 5) whereas nicotine was ineffective",
      "key": "70f0603edaf0015415473aa35ec4e3819c8177f5ede18166931485732e465a6b90357cbe56adaa2dafaab8a7252e8564b01366b20ef12dab33985ac6ae29578e",
      "line": 132,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 3,
      "target": 11
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "CellLine": {
          "HEK293": true,
          "SH-SY5Y": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "In addition, an inhibition of p65 NFκB phosphorylation was observed following treatment with anatabine in 7W CHO overexpressing APP (Fig. 6A), in HEK293 (Fig. 6B) and in human neuronal like SH-SY5Y cells (Fig. 6C) showing that anatabine can prevent NFκB activation in various cell lines.",
      "key": "51fc27d3065a43553ef3d6df9ee5f6886574cc81abe019b0ea5eba63acc4adc917c58117c4158225eb24e9d9bdf2d5e72ae26dc48f9bcef63e35ca716c370569",
      "line": 147,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 3,
      "target": 11
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "Since BACE-1 transcription is regulated by NFκB (Buggia-Prevot et al., 2008) and since we have shown that anatabine inhibits NFκB activation, we investigated the effect of anatabine on BACE-1 transcription using human neuronal like SH-SY5Y cells",
      "key": "a420c76a2c404f8cccdcca470330777572f3f8846cb8449797b8edf276846947ba4ac3a15e9516d6400904585077aa29072d95c65fc142c53c9bbd3cb7b200e8",
      "line": 156,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 3,
      "target": 11
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "Since anatabine lowers NFκB activation in vitro, we explored the possibility that anatabine may affect the level of C-reactive protein (CRP) whose expression is NFκB dependent (Karlsen et al., 2010; Yang et al.,2010).",
      "key": "a3503a0f7c911f4c9ed2c831fd08b7fde1c27400cc94619fed4b0fadf87b3999587ead8de0be00b026206d20676dff8d96adb826b59276fa02fee3f8e603ffb5",
      "line": 201,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 3,
      "target": 11
    },
    {
      "annotations": {
        "CellLine": {
          "CHO cell": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "In addition, an inhibition of p65 NFκB phosphorylation was observed following treatment with anatabine in 7W CHO overexpressing APP (Fig. 6A), in HEK293 (Fig. 6B) and in human neuronal like SH-SY5Y cells (Fig. 6C) showing that anatabine can prevent NFκB activation in various cell lines.",
      "key": "fc237f853d199f9d042296ea72633c9ff392b05dc3af33f54281b3dd0f384f45e865ee3c0ab567439540969ece141791f7be3cb93478684951693ff724204e34",
      "line": 143,
      "relation": "decreases",
      "source": 3,
      "target": 19
    },
    {
      "annotations": {
        "CellLine": {
          "SH-SY5Y": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "As expected, TNFα greatly stimulated BACE-1 transcription whereas anatabine fully prevented the increase in BACE-1 mRNA levels induced by TNFα (Fig. 7A).",
      "key": "9e4e56a574bfdca76c49678a41b8726686482a12876bd622384b7605001d70ab7cf2a971a5e107b8008cf3b879ada502245fcf0474ca1fed0103779a47d578ff",
      "line": 165,
      "relation": "decreases",
      "source": 3,
      "target": 21
    },
    {
      "annotations": {
        "CellLine": {
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "Following 24 h of treatment, a dose dependent inhibition of BACE-1 protein levels was observed with anatabine (Fig. 7B)",
      "key": "244c52f0215492dac46cb8fac4e083378d69c3c7e4d95b6db6cf4999c0ba779b196b23e03d8db234b919a55946012bd1bc255e7ca3cc87c4f8cfcd245529eeab",
      "line": 171,
      "relation": "decreases",
      "source": 3,
      "target": 15
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Plasma": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "In addition, a significant decreased in plasma Aβ levels was observed in mice treated with anatabine consistent with an inhibition of Aβ production (Fig. 10).",
      "key": "0c3166fae62fa2bf5866d647372ae798c51cf88771490272dc83d7bace9f9f7e9bbc6b89f5c5185510ea31b54fdd7fb373dc94f3d6cb7cc769fef1d0f9c526f3",
      "line": 193,
      "relation": "decreases",
      "source": 3,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Plasma": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "A statistically significant reduction in plasma CRP levels was observed following the 2 mg/kg treatment with anatabine showing that at this dosage anatabine displays an anti-inflammatory activity in vivo (Fig. 11).",
      "key": "246e7618a8cd7df659003e624c6f124ad14b1c3b76b213f37706658fa03d66dffb72df80f6862deeb5b11df163a4517b8d06924900d20db36357bff980403eb1",
      "line": 210,
      "relation": "decreases",
      "source": 3,
      "target": 16
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Plasma": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "A statistically significant reduction in plasma CRP levels was observed following the 2 mg/kg treatment with anatabine showing that at this dosage anatabine displays an anti-inflammatory activity in vivo (Fig. 11).",
      "key": "ddd4eb87bcca895437279fdff2382c2bbb7ebda961b6671d26084091cb863654bdf9615ceee530f7ec7591b409f418ea916f03956a8062018df6df6d6efad196",
      "line": 211,
      "relation": "negativeCorrelation",
      "source": 3,
      "target": 10
    },
    {
      "annotations": {
        "CellLine": {
          "CHO cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "Contrary to anatabine, (−)-nicotine and other nicotinic acetylcholine receptors agonists and antagonists do not inhibit Aβ production by 7W CHO cells (Fig. 3).",
      "key": "0d3845746a3671531318809679e70a53885e774e107dd33e1bcaf687eb37ad24fea106608d60348fe89df5c34cda4b264bd048a99e18454462fed26917fc814e",
      "line": 98,
      "relation": "causesNoChange",
      "source": 8,
      "target": 2
    },
    {
      "annotations": {
        "CellLine": {
          "CHO cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "Contrary to anatabine, (−)-nicotine and other nicotinic acetylcholine receptors agonists and antagonists do not inhibit Aβ production by 7W CHO cells (Fig. 3).",
      "key": "3bcf993b7e94db191a01fffd0dd3b349c8a0a9a3e56922660ebc59990bc89c31d5619330dea89f82a29eaaf31c0d93efc5b2beefd8107444fb35c1c197546e0f",
      "line": 99,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 8,
      "target": 5
    },
    {
      "annotations": {
        "CellLine": {
          "CHO cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "Contrary to anatabine, (−)-nicotine and other nicotinic acetylcholine receptors agonists and antagonists do not inhibit Aβ production by 7W CHO cells (Fig. 3).",
      "key": "c7f1890aa6957ef6c5ab62fa0dd9b173a419c04823256b84b8bce934ad4238b395dfd29634f2e546cac56b3b4fb1325386c06403fd6e397f2973b085917f400d",
      "line": 100,
      "relation": "causesNoChange",
      "source": 4,
      "target": 2
    },
    {
      "annotations": {
        "CellLine": {
          "CHO cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "Contrary to anatabine, (−)-nicotine and other nicotinic acetylcholine receptors agonists and antagonists do not inhibit Aβ production by 7W CHO cells (Fig. 3).",
      "key": "01b59e4235125fc33c5b98ad171d58496733f734697c181e0ba5e0a172fc44273033ef3b1d718410245848ff983a88820d4d376003cb1397b06f31e60f9ea04d",
      "line": 101,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 4,
      "target": 5
    },
    {
      "annotations": {
        "CellLine": {
          "CHO cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "Nicotine does not appear to affect sAPPβ and sAPPα secretion in 7W CHO contrary to anatabine (Fig. 4)",
      "key": "1da8a5db8198ed4dc6ce9d35238ef87354645334e2d67f1b30afe588bdd9bfa37e8c69f1580c46738dd4605df69dbc90868eac97d1c2842dc80907b17c6faa3f",
      "line": 122,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "causesNoChange",
      "source": 4,
      "target": 14
    },
    {
      "annotations": {
        "CellLine": {
          "CHO cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "Nicotine does not appear to affect sAPPβ and sAPPα secretion in 7W CHO contrary to anatabine (Fig. 4)",
      "key": "517ec0555ab7a2e1d2e75c5f74a19270d3d9f4c3a99d0b7a0a6bacc47760e5bb61042de07d46c3a32db73a607c619ea046da74ace9224bfc04a2d3f54db4276a",
      "line": 123,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "causesNoChange",
      "source": 4,
      "target": 13
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "We observed that anatabine dose dependently inhibited NFκB activation by TNFα in HEK293 NFκB luciferase reporter cells (Fig. 5) whereas nicotine was ineffective",
      "key": "ecbbde9706ef851299bb78bc5e12fb9f98463098c5f272258b6f4b470665e02bde89b107f05e51e5a88ad570adab19e0ce148899d1f8017349c40a31a2733e3f",
      "line": 134,
      "object": {
        "modifier": "Activity"
      },
      "relation": "causesNoChange",
      "source": 4,
      "target": 11
    },
    {
      "annotations": {
        "CellLine": {
          "CHO cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "Contrary to anatabine, (−)-nicotine and other nicotinic acetylcholine receptors agonists and antagonists do not inhibit Aβ production by 7W CHO cells (Fig. 3).",
      "key": "678e3239de8551c7cfa953780bc2e022524d8b0f7226524dc4b38673e44f58cccb260cf24fc66c517c80e10ad063173c44dc757d3cd9b9ff7f7a0df7f9e8cea9",
      "line": 102,
      "relation": "causesNoChange",
      "source": 7,
      "target": 2
    },
    {
      "annotations": {
        "CellLine": {
          "CHO cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "Contrary to anatabine, (−)-nicotine and other nicotinic acetylcholine receptors agonists and antagonists do not inhibit Aβ production by 7W CHO cells (Fig. 3).",
      "key": "eed6afad43a12d0b8f631dfc7ca908fb9b4e41b0ead9bcdab0c01bb8c7f5d0e226eb5293fa01183e9bc4a6b88426e86609c5d6e498222b7e9a8134776925a642",
      "line": 103,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 7,
      "target": 5
    },
    {
      "annotations": {
        "CellLine": {
          "CHO cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "Contrary to anatabine, (−)-nicotine and other nicotinic acetylcholine receptors agonists and antagonists do not inhibit Aβ production by 7W CHO cells (Fig. 3).",
      "key": "889e4540786398f59c4eadabc49d146ba5685ec226ec43b29c7e9b3e7520438dc82781f769bb7d3400072c253a26a07c9ad8b9264666caf9b7534bed915acec3",
      "line": 104,
      "relation": "causesNoChange",
      "source": 12,
      "target": 2
    },
    {
      "annotations": {
        "CellLine": {
          "CHO cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "Contrary to anatabine, (−)-nicotine and other nicotinic acetylcholine receptors agonists and antagonists do not inhibit Aβ production by 7W CHO cells (Fig. 3).",
      "key": "30323691428bb0b054d89364e44c433c87dbb08f0403d996d5cb180b2aaf0f24cb69dfd0d825901a7936eaefceeabd8a3439e272da4477d178abf67dae93d315",
      "line": 105,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 12,
      "target": 5
    },
    {
      "annotations": {
        "CellLine": {
          "CHO cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "Contrary to anatabine, (−)-nicotine and other nicotinic acetylcholine receptors agonists and antagonists do not inhibit Aβ production by 7W CHO cells (Fig. 3).",
      "key": "4d6bf0278ddb4dfa80ee7f0bd2d03658b5a8f961d6e09b23ff81a4c59e3a61ccce4269ff4bdfcacdbde442a838c2c319b20911926822fb911ee202371b78b45e",
      "line": 106,
      "relation": "causesNoChange",
      "source": 6,
      "target": 2
    },
    {
      "annotations": {
        "CellLine": {
          "CHO cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "Contrary to anatabine, (−)-nicotine and other nicotinic acetylcholine receptors agonists and antagonists do not inhibit Aβ production by 7W CHO cells (Fig. 3).",
      "key": "1cff184ac2ef3e235ff0246b619c4fe849562f4a9136bc83b9636980004fe9d2319324e4145c71366f6f0f30c19a75aff3872710b472a5beefd97e77a77fdc0a",
      "line": 107,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 6,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "Since BACE-1 transcription is regulated by NFκB (Buggia-Prevot et al., 2008) and since we have shown that anatabine inhibits NFκB activation, we investigated the effect of anatabine on BACE-1 transcription using human neuronal like SH-SY5Y cells",
      "key": "b07d78cfd351ebb2eaa17641d01f330cba23bf831295d6539ba85cd0afcc2589877980dbd5a7686a5a92cd370b3fb85186d916d89c5c1208a2b2f944c0ad3117",
      "line": 155,
      "relation": "regulates",
      "source": 11,
      "target": 21
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "Since anatabine lowers NFκB activation in vitro, we explored the possibility that anatabine may affect the level of C-reactive protein (CRP) whose expression is NFκB dependent (Karlsen et al., 2010; Yang et al.,2010).",
      "key": "22b4bd3bc3d8778cd449d518ecb0843713433d764b06ea651ec76a1b62c02f01ba82e9d0a5e3b5391e606077c5084432cf9fbea402c203f76144abedd97e1490",
      "line": 202,
      "relation": "regulates",
      "source": 11,
      "target": 16
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "We observed that anatabine dose dependently inhibited NFκB activation by TNFα in HEK293 NFκB luciferase reporter cells (Fig. 5) whereas nicotine was ineffective",
      "key": "653fa3ff36cf4133057da947ff9cc133d7f46e3e6df6ab404171b7c2a25dcf956ad81a991ac2584b435df5ec9528f830b583139f088b33f300afee7cd5087757",
      "line": 133,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 20,
      "target": 11
    },
    {
      "annotations": {
        "CellLine": {
          "SH-SY5Y": true
        },
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "As expected, TNFα greatly stimulated BACE-1 transcription whereas anatabine fully prevented the increase in BACE-1 mRNA levels induced by TNFα (Fig. 7A).",
      "key": "a10ee1fa34754f33c45b64b480df57b255ae45abacd52685ac695e47e1db6dab9425d82f2213c60f3dedf07bd855594190e2ad02b2f44f8da93b1a3766489b0b",
      "line": 164,
      "relation": "increases",
      "source": 20,
      "target": 21
    },
    {
      "key": "3fcf9da549a1e7a9932a20769eafaaf5b64e9fa82b38b57bfa5734d49332c3ae8fb40859085e8f970f49a15de4df46fa920124a4ddee2238ca6b91cb996401b3",
      "relation": "hasVariant",
      "source": 18,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Plasma": true
        }
      },
      "citation": {
        "authors": [
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Bishop A",
          "Chao J",
          "Crawford F",
          "Mathura V",
          "Mullan M",
          "Paris D",
          "Reed J"
        ],
        "date": "2011-11-30",
        "first": "Paris D",
        "last": "Mullan M",
        "name": "European journal of pharmacology",
        "pages": "384-91",
        "reference": "21958873",
        "title": "Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.",
        "type": "PubMed",
        "volume": "670"
      },
      "evidence": "A statistically significant reduction in plasma CRP levels was observed following the 2 mg/kg treatment with anatabine showing that at this dosage anatabine displays an anti-inflammatory activity in vivo (Fig. 11).",
      "key": "75aa83fa6c617225ff955a1082827c1cae2f447d2402994d3ac579f5e1a1a972fcf0b531f953ec553329851760dc47c9bead323cc7c50385d6a21f402fd8675e",
      "line": 211,
      "relation": "negativeCorrelation",
      "source": 10,
      "target": 3
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"amyloid-beta polypeptide 40\")",
      "function": "Abundance",
      "id": "2ca2eb795438fe9e0f24c1e9d332717de5e344ddfee00ce8df89c5b901d85db5994d6ffd383e40a90bde264f33e75b220476b3de86c89f0658bf281c872f0bb6",
      "name": "amyloid-beta polypeptide 40",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"amyloid-beta polypeptide 42\")",
      "function": "Abundance",
      "id": "c2da54109c90719396dfdfb558be74582b8522863849a50f3f5029b7d60f4d53df3cfa1a97b787e760a2f74ea1f74012eb49273beeded42a2873d788953b4a13",
      "name": "amyloid-beta polypeptide 42",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"amyloid-beta\")",
      "function": "Abundance",
      "id": "a9487b29439483c6840095610dd3e496e3ca9cccc3a8d71e0385a39b570f3c0a26965ac06d83265e1c08deaae7998272d4f4c21ec0534f8be3fd8e4e57dbb3a2",
      "name": "amyloid-beta",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:Anatabine)",
      "function": "Abundance",
      "id": "c77d4080804731f0ef07ad52ed2fbccdac5d02fb2620d8800d273e925feebcbf90b94a2399efeb42a91e65413550e0f713cd431329129e1cdd90329cae6b3ff6",
      "name": "Anatabine",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:nicotine)",
      "function": "Abundance",
      "id": "81813864e07e0e955a0ccf7e9ec2430ce5cdbeae237c18991897f8314b29bdb2d0985dedfa71377ab67541fbcea0567e323d0cf47a5517efc83a67ac442abdb8",
      "name": "nicotine",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(MESH:\"Receptors, Nicotinic\")",
      "function": "Abundance",
      "id": "ab9ab8a42f27ea8b317e817b34a7ed7609808e3ccad71f0ce8685fa7b9e53fd847534ce7483452cc11f2166657f178e8e6804466c34019ef9674372b725b155d",
      "name": "Receptors, Nicotinic",
      "namespace": "MESH"
    },
    {
      "bel": "a(PUBCHEM:11957537)",
      "function": "Abundance",
      "id": "6a1b15b298682ac1cb87a669e93b0b3dc76b168d6e3c7aadc0540338d671e8c7c766a62494115216aee2dc5143c657a7b577e931a07d608d50536d280d29a45e",
      "name": "11957537",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:56972222)",
      "function": "Abundance",
      "id": "19c5f54250750101d63c53cc2af2761b803199de338b2d5a8228f1787698437075af45f7b11ebcab56d13060033cca1b83681b32b351e649bcc85e5d2fa687f7",
      "name": "56972222",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:71311633)",
      "function": "Abundance",
      "id": "eb5e4f9abe2af35ea0d1b97037cad16b1434175b976d08cd063f4fb8af9cce7fd3011896b904805f39952e504f07a4f1d92ef80b541673ccb28bc92aab1f2225",
      "name": "71311633",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "bp(GO:\"amyloid-beta formation\")",
      "function": "BiologicalProcess",
      "id": "78b3edf87ac63c62c4027270412a8d18bf9cded8d1db6354615c4b7e79930f50560150fde88c2996f8bafaefe2809ece6b1f9300ff1e79f0aad756ba51d9a65e",
      "name": "amyloid-beta formation",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"inflammatory response\")",
      "function": "BiologicalProcess",
      "id": "422dfc2db00b1d942862470cbabe1e8312bf97b25050190db5ae19636adae95f4fa18c512574526825bd377b16c2278899435eb759e951ba850ad476e14f9900",
      "name": "inflammatory response",
      "namespace": "GO"
    },
    {
      "bel": "complex(GO:\"NF-kappaB complex\")",
      "function": "Complex",
      "id": "3a4beef8af5f67742530b7b03a9535e4664bc86a324a25de89afd477ba2255b35861613031edeeed3c3779d3496452af049029d0be0a96abdb872b1dc261487a",
      "name": "NF-kappaB complex",
      "namespace": "GO"
    },
    {
      "bel": "p(CONSO:\"alpha-Bungarotoxin\")",
      "function": "Protein",
      "id": "867336789943562f90ca36ac586326185a782e933493e2b012e1728e42b40d270f20d29675f3bccdf7ee2956289514d3f40ffd53636f17d01776120f1593110b",
      "name": "alpha-Bungarotoxin",
      "namespace": "CONSO"
    },
    {
      "bel": "p(CONSO:\"sAPP-alpha\")",
      "function": "Protein",
      "id": "ed93b0dc34eaef3af160558aee0b3a7ddac2727804ae9edba36ae15828b0209345d1f55a65b19b68604395ec17d3900de157f1a39fd6519540b3d4f3d48d475e",
      "name": "sAPP-alpha",
      "namespace": "CONSO"
    },
    {
      "bel": "p(CONSO:\"sAPP-beta\")",
      "function": "Protein",
      "id": "5398d4984129759e9b240bafa6b1c68a4fa29a53cd3b11c8c3e9a0cf7ed4ad658837071ea10d874d9f67aa0a38eda520f01d74ce3462dcdcad62c2669f34828d",
      "name": "sAPP-beta",
      "namespace": "CONSO"
    },
    {
      "bel": "p(HGNC:BACE1)",
      "function": "Protein",
      "id": "88f17e7dffb6947c01414f79e5a3bb9cdd3e932c355af7f0c8907d2b5d07742883eaf63866fe7fc938401ce0c366856fd5e306f324e6c1f474c1a984c8e46a51",
      "name": "BACE1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:CRP)",
      "function": "Protein",
      "id": "6c85ddd09e7197988cc4ac0e5cff11456fb48df2f086f54f1aaac48c3d7a12a8a6b576d3b923e8cc13cc19eb6723e863d17ee1684a2938d340257ac1bae39ce9",
      "name": "CRP",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:LDHA)",
      "function": "Protein",
      "id": "ee211cdf366cfa758101f201752c88a1253daf7ee76618d88181ad9e175b53e7e91b615bc2c7e2a40283b80bb7b76cdc558790d94e216443ba080e93130be2fe",
      "name": "LDHA",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:RELA)",
      "function": "Protein",
      "id": "02493376083b06f6044a237f4e756f227621391970d2c53693da442582176f53d992abe2f0fd0b28f8a305ab5f3429be4b4d20bd7fd4302ae88cf1eb87fe7e40",
      "name": "RELA",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:RELA, pmod(Ph))",
      "function": "Protein",
      "id": "d51b9a8eb62ec08dc863472ef97b53eab28965cccd38adc932c625c25bbe0a563c50d39c467cb8d3bef104cab2430c5701227bbd62143b608a4a5d4be54c25bc",
      "name": "RELA",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:TNF)",
      "function": "Protein",
      "id": "a262f5edbfb734dd0ec9696a3b78644fccfb4054a9cf9225beb17c33ef416a75809ff59ec1646e29a3cccc804c9294f8d2c48120af9f5ee98e764a584626426d",
      "name": "TNF",
      "namespace": "HGNC"
    },
    {
      "bel": "r(HGNC:BACE1)",
      "function": "RNA",
      "id": "7a8568c6a73744c08bc8ed3703f3eef2f933911dbe9dae8311ac46e3d08142e14304751f4daec9b68714f7c8b28ec250df2e1ed4f91bd3469c309a95e46b89b4",
      "name": "BACE1",
      "namespace": "HGNC"
    }
  ]
}